MANAGEMENT OF NEUROPATHIC PAIN: A REVIEW OF CURRENT TRENDS .

Abstract

The International Association for the Study of Pain (IASP) defines “pain” as “an unpleasant sensory and emotional experience associated with actual or potential tissue damage or described in terms of such damage. Pain is a common symptom that knows no boundary. It differs with age, creed, sex, disease and specialty.

 Neuropathic pain is defined as pain arising as a direct consequence of a lesion or disease affecting the somatosensory system. Its chronic debilitating nature and unpredictive response to medication make it a challenge to most physicians and the patient they treat. The use of treatment algorithms or guidelines have found common use in the treatment of neuropathic pain. This poses a need for periodic review.

This review looked at the current trends in the management of neuropathic pain. We recommend a four-pronged approach in the evaluation and management of patients with neuropathic pain. This involved detailed review of the patient, the pain, the plan, and the pill. There is also a growing need to adopt less invasive techniques in the treatment of chronic recalcitrant pain.

Keywords:

Neuropathic, Pain, chronic, trend, review

References

Nishikawa N. Treatment of neuropathic pain. J Jpn Soc Int Med. 2013; 102.

Loesera JD, Treedeb RD. The Kyoto protocol of IASP Basic Pain Terminology. Pain 2008;137: 473–477.

Costigan M, Scholz J, Woolf CJ. Neuropathic pain: a maladaptive response of the nervous system to damage. Annu Rev Neurosci 2009; 32: 1–32

Bouhassira D, Lantéri‐Minet M, Attal N. Prevalence of chronic pain with neuropathic characteristics in the general population. Pain. 2008; 136: 380–387.

Nikolajsen L, Jensen TS. Phantom limb pain. Br J Anaesth 2001; 87: 107–16

Dermanovic Dobrota, V., Hrabac, P., Skegro, D. The impact of neuropathic pain and other comorbidities on the quality of life in patients with diabetes. Health Qual Life Outcomes 2014; 12, 171-73 .

Miaskowski C, Nurmikko TJ, Portenoy RK, et al. Pharmacologic management of neuropathic pain: evidence‐based recommendations. Pain 2007;132:237–251.]

Attal N, Cruccu G, Haanpää M. European Federation of Neurologic Society guidelines on pharmacological treatment of neuropathic pain. Eur J Neurol 2006;13:1153–1169.

Nishikawa N, Nomoto M, Management of neuropathic pain. J Gen Fam Med. 2017 ; 18(2): 56–60.

Chijioke E, Duncan S, Chang-Gyu H, Dysregulations of Synaptic Vesicle Trafficking in Schizophrenia. Current Psychiatry Reports 2016; 18(8): 120-122

von Hehn CA, Baron R, Woolf CJ. Deconstructing the neuropathic pain phenotype to reveal neural mechanisms. Neuron 2012; 73: 638–652.

Baron R, Binder A, Wasner G. Neuropathic pain: diagnosis, pathophysiological mechanisms, and treatment. Lancet Neurol 2010; 9: 807–819.

Sytze Van DP, Cotter MA, Bravenboer B, Cameron NE. Pathogenesis of diabetic neuropathy: focus on neurovascular mechanisms. Eur J Pharmacol 2013; 719: 180–186.

Costigan M, Scholz J, Woolf CJ. Neuropathic pain: a maladaptive response of the nervous system to damage. Annu Rev Neurosci 2009; 32: 1–32.

Eisenberg E, Sandler I, Treister R, Suzan E, Haddad M. Anti-tumour necrosis factor - alpha adalimumab for complex regional pain syndrome type 1 (CRPS-I): a case series. Pain Pract 2013; 13: 649–656.

Gordon DB, Dahl JL, Miaskowski C, McCarberg B, Todd KH, Paice JA, et al. American Pain Society recommendations for improving the quality of acute and cancer pain management: Am Pain Soc Qual of Care Task Force 2005. Arch Intern Med 2005 ;165(14):1574–1580.

Dubois MY, Gallagher RM, Lippe PM. Pain medicine position paper. Pain Med 2009;10(6):972–1000.

Matthias MS, Parpart AL, Nyland KA, Huffman MA, Stubbs DL, Sargent C, et al. The patient–provider relationship in chronic pain care: providers' perspectives. Pain Med 2010; 11 (11):1688–1697.

McCormack LA, Treiman K, Rupert D, Williams-Piehota P, Nadler E, Arora NK, et al. … Measuring patient-centered communication in cancer care: A literature review and the development of a systematic approach. Soc Sci Med 2011; 72:1085–1095.

Epstein RM, Duberstein PR, Fenton JJ, Fiscella K, Hoerger M, Tancredi DJ,et al. Effect of a patient-centered communication intervention on oncologist-patient communication, quality of life, and health care utilization in advanced cancer: the VOICE randomized clinical trial. JAMA Oncol 2017;3(1), 92–100.

Robinson JH, Callister LC, Berry JA, Dearing KA. Patient-centered care and adherence: Definitions and applications to improve outcomes. J Am Assoc Nurse Pract 2008;20(12):600–607.

Finnerup NB, Attal N, Haroutounian S. Pharmacotherapy for neuropathic pain in adults: A systematic review and meta-analysis. Lancet Neurol 2015; 14(2): 162–173.

Cohen SP, Bicket MC, Jamison D, Wilkinson I, Rathmell JP. Epidural steroids: a comprehensive, evidence-based review. Reg Anesth Pain Med 2013;38:175–200.

124. Chou R, Rodin H, Janna F, Fu R, Christiana B, Tracy D, Sean D, Jeffrey J. Epidural corticosteroid injections for radiculopathy and spinal stenosis: a systematic review and meta-analysis. Ann Intern Med 2015; 163:373–381.

. Dworkin RH, , O’connor AB, Kent J, Mackay SC, Raja SN, Stacey BR, et al. Interventional management of neuropathic pain: NeuPSIG recommendations. Pain 2013; 154: 2249–2261.

Neal JM. Anatomy and pathophysiology of spinal cord injury associated with regional anesthesia and pain medicine. Reg Anesth Pain Med 2008 t; 33(5):423-434.

Laemmel E, Segal N, Mirshahi M, Azzazene D, Le Marchand S, Wybier M, et al.. Deleterious Effects of Intra-arterial Administration of Particulate Steroids on Microvascular Perfusion in a Mouse Model. Radiol 2016 ; 279(3):731-740.

Epstein NE. The risks of epidural and transforaminal steroid injections in the Spine: Commentary and a comprehensive review of the literature. Surg Neurol Int 2013; 4(Suppl 2):S74-S93.

Atluri S, Glaser SE, Shah RV, Sudarshan G. Needle position analysis in cases of paralysis from transforaminal epidurals: consider alternative approaches to traditional technique. Pain Physician 2013 J; 16 (4):321-34.

Chakravarthy K, Richter H, Christo PJ, Williams K, Guan Y. Spinal cord stimulation for treating chronic pain: reviewing preclinical and clinical data on paresthesia-free high-frequency therapy. Neuromodulation 2018; 21(1):10–18.

Chandran P, Sluka KA. Development of opioid tolerance with repeated transcutaneous electrical nerve stimulation administration. Pain 2003; 102 (1–2):195–201.

De Ridder D, Vancamp T, Vanneste S. Fundamentals of burst stimulation of the spinal cord and brain. In: Neuromodulation: 1st Edi. De Ridder D, Elsevier; 2018. p. 147–60.

Elaine TK, Tasker RR, Nicosia S, Michael LW, Mikulis DJ. Functional magnetic resonance imaging: a potential tool for the evaluation of spinal cord stimulation: technical case report. Neurosurg. 1997; 41 (2):501–504.

Foreman R, Beall J, Coulter J, Willis W. Effects of dorsal column stimulation on primate spinothalamic tract neurons. J Neurophysiol 1976; 39(3):534–546.

Deer TR, Esposito MF, McRoberts WP, Grider JS, Sayed D, Verrills P, et al. A Systematic Literature Review of Peripheral Nerve Stimulation Therapies for the Treatment of Pain. Pain Med 2020 Aug ;21 (8):1590-1603.

Mobbs RJ, Nair S, Blum P. Peripheral nerve stimulation for the treatment of chronic pain. J Clin Neurosci 2007 ;14 (3):216-21;

Nashold BS, Goldner JL, Mullen JB, Bright DS. Long-term pain control by direct peripheral-nerve stimulation. J Bone Joint Surg Am 1982 ; 64 (1):1-10.

Deer TR, Jain S, Hunter C, Chakravarthy K. Neurostimulation for Intractable Chronic Pain. Brain Sci 2019 24;9(2)

Deer TR, Grider JS, Lamer TJ, Pope JE, Falowski S, Hunter CW, et al. A Systematic Literature Review of Spine Neurostimulation Therapies for the Treatment of Pain. Pain Med. 2020 ;21 (7):1421-1432.

Luedtke K, Rushton A, Wright C, Geiss B, Juergens TP, May A "Transcranial direct current stimulation for the reduction of clinical and experimentally induced pain: a systematic review and meta-analysis". Clin J Pain 2012; 28 (5): 452–461.

Soler MD, Kumru H, Pelayo R, Vidal J, Tormos JM, Fregni F, et al.. "Effectiveness of transcranial direct current stimulation and visual illusion on neuropathic pain in spinal cord injury". Brain 2010; . 133 (9): 2565–2577.

Jain S, Malinowski M, Chopra P, Varshney V, Deer TR. Intrathecal drug delivery for pain management: recent advances and future developments. Expert Opin Drug Deliv 2019 ; 16(8):815-822.

Urman RD, Böing EA, Khangulov V, Fain R, Nathanson BH, Wan GJ, et al. Analysis of predictors of opioid-free analgesia for management of acute post-surgical pain in the United States. Curr Med Res Opin 2019 ;35 (2):283-289.

Bates D, Schultheis BC, Hanes MC, Jolly SM, Chakravarthy KV, Deer TR, et al. A Comprehensive Algorithm for Management of Neuropathic Pain. Pain Med. 2019 Jun 1;20(Suppl 1):S2-S12.. Erratum in: Pain Med 2023 ;24(2):219-20.

Haanpää ML, Backonja MM, Bennett MI. Assessment of neuropathic pain in primary care. Am J Med 2009;122(Suppl 10):S13–21.

Dworkin RH, O'Connor AB, Audette J. Recommendations for the pharmacological management of neuropathic pain: An overview and literature update. Mayo Clinic Proc 2010;85(3, Suppl):S3–S14.

National Institute for health and Care Excellence. Neuropathic pain in adults: Pharmacological management in non-specialist settings. NICE, Clinical Guideline. 2013.

2. Finnerup NB, Attal N, Haroutounian S, Pharmacotherapy for neuropathic pain in adults: A systematic review and meta-analysis and updated NeuPSIG recommendations. Lancet Neurol 2015;142:162–173.

3. Sumitani M, Sakai T, Matsuda Y. Executive summary of the clinical guidelines of pharmacologic therapy for neuropathic pain: Second edition by the Japanese Society or Pain Clinicians. J Anesth 2018;323:463–478.

Gilron I, Bailey JM, Tu D, et al. Nortriptyline and gabapentin, alone and in combination for neuropathic pain: A double-blind, randomized controlled crossover trial. Lancet 2009; 3749697:1252–1261.

Sindrup SH, Andersen G, Madsen C. Tramadol relieves pain and allodynia in polyneuropathy: A randomized, double-blind, controlled trial. Pain 1999;831:85–90.

Boureau F, Legallicier P, Kabir-Ahmadi M. Tramadol in post-herpetic neuralgia: A randomized, double-blind, placebo-controlled trial. Pain 2003;104(1–2):323–331.

Schwartz S, Etropolski M, Shapiro DY. Safety and efficacy of tapentadol ER in patients with painful diabetic peripheral neuropathy: Results of a randomized-withdrawal, placebo-controlled trial. Curr Med Res Opin 2011;271:151–162.

Chou R, Loeser JD, Owens DK. Interventional therapies, surgery, and interdisciplinary rehabilitation for low back pain: An evidence-based clinical practice guideline from the American Pain Society. Spine ( 2009;3410:1066–1077.